Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

Back

ESC Professional Premium Access

Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

Session: Complex and novel interventions for heart failure

Topic: Multidisciplinary Interventions

Speaker: Doctor E. Zancanaro (Milan, IT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Edoardo Zancanaro

University Vita-Salute San Raffaele, Milan (Italy)

1 presentation

0 follower

7 more presentations in this session

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Speaker: Doctor B. Wang (Galway, IE)

Access

Abstract

Slides

Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

Speaker: Doctor C. Waechter (Marburg, DE)

The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Speaker: Doctor C. Paitazoglou (Luebeck, DE)

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

Speaker: Mrs M. Rivadeneira Ruiz (Madrid, ES)

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Speaker: Doctor H. Williams (Bristol, GB)

Access the full session

Complex and novel interventions for heart failure

Speakers: Doctor E. Zancanaro, Doctor B. Wang, Doctor C. Waechter, Doctor C. Paitazoglou, Mrs M. Rivadeneira Ruiz...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Tricuspid regurgitation and heart failure: the faith of treated vs untreated cohort in the percutaneous era

About the speaker

Doctor Edoardo Zancanaro

7 more presentations in this session

Transcatheter endomyocardial alginate-hydrogel injection for treatment of heart failure

Interventional rhythm control is associated with an improved long-term prognosis of patients with atrial fibrillation undergoing transcatheter edge-to-edge mitral valve repair

The PRELIEVE trial:Final 1-year outcomes of the prospective atrial flow regulator study

Impact of sacubitril valsartan initiation in patients with HFrEF and severe mitral regurgitation referred for percutaneous mitral repair

A proactive care pathway that improves medical therapy for patients with heart failure with reduced ejection fraction and implantable cardiac devices

Access the full session

Complex and novel interventions for heart failure

About the event

ESC Congress 2023

ESC 365 is supported by